Advanz and private equity groups fined for 1,000% drug price increase
Drug prices updates Sign up to myFT Daily Digest to be the first to know about Drug prices news. The UK competition regulator has fined Advanz Pharma and private equity groups Cinven and Hg a total of £100m for increasing the price of a thyroid drug by more than 1,000 per cent over eight years. … Read more